Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2018 / Article
Special Issue

Modulation of Redox Signaling in Chronic Diseases and Regenerative Medicine

View this Special Issue

Research Article | Open Access

Volume 2018 |Article ID 1724648 | https://doi.org/10.1155/2018/1724648

Hongyang Jiang, Xintao Gao, Jianan Gong, Qian Yang, Ruzhu Lan, Tao Wang, Jihong Liu, Chunping Yin, Shaogang Wang, Zhuo Liu, "Downregulated Expression of Solute Carrier Family 26 Member 6 in NRK-52E Cells Attenuates Oxalate-Induced Intracellular Oxidative Stress", Oxidative Medicine and Cellular Longevity, vol. 2018, Article ID 1724648, 15 pages, 2018. https://doi.org/10.1155/2018/1724648

Downregulated Expression of Solute Carrier Family 26 Member 6 in NRK-52E Cells Attenuates Oxalate-Induced Intracellular Oxidative Stress

Academic Editor: Claudia Penna
Received04 Jul 2018
Revised25 Aug 2018
Accepted01 Sep 2018
Published10 Oct 2018


Solute carrier family 26 member 6 (Slc26a6), which is mainly expressed in the intestines and kidneys, is a multifunctional anion transporter that is crucial in the transport of oxalate anions. This study is aimed at investigating the effect of Slc26a6 expression on oxalate-induced cell oxidation and crystal formation. Lentivirus transfection was used to upregulate or downregulate Slc26a6 expression in NRK cells. Cell viability and apoptosis, reactive oxygen species (ROS) and malondialdehyde (MDA) generation, and superoxide dismutase (SOD) activity were measured. Crystal adhesion and the cell ultrastructure were observed using light and transmission electron microscopy (TEM). Three groups of rats, normal control, lentivirus-vector, and lentivirus-small interfering RNA (lv-siRNA) groups, were used, and after lentivirus transfection, they were fed 1% ethylene glycol (EG) and 0.5% ammonium chloride (NH4Cl) for 2 weeks. Dihydroethidium (DHE), terminal deoxynucleotidyl transferase (TdT) deoxyuridine dUTP nick-end labeling (TUNEL), and von Kossa staining were performed, and nuclear factor κB (NFκB) and osteopontin (OPN) expression were measured. In the vitro study, compared to the control group, downregulated Slc26a6 NRK cells showed alleviation of the cell viability decrease, cell apoptosis rate, ROS generation, and SOD activity decrease after oxalate treatment. Crystal adhesion and vesicles were significantly less after oxalate exposure than in the untreated controls. Rats infected with lentivirus-siRNA exhibited attenuated SOD generation, cell apoptosis, and crystal formation in the kidneys. Increased phosphorylation of NFκB and OPN was involved in the pathological process. In conclusion, the results of the present study indicate that reducing the expression of Slc26a6 in the kidney may be a potential strategy for preventing stone formation.

1. Introduction

Urolithiasis is a common disease caused by a combination of metabolic and genetic risk factors [1, 2] which is characterized by the development of stony concretions in the bladder or urinary tract. Calcium oxalate (CaOx) stones are the most prevalent type of kidney stones, accounting for 70–80% of incidences [3]. Hyperoxaluria is a major risk factor for CaOx urolithiasis and is the result of both genetic and environmental factors. Enhanced absorption of oxalate by the intestine, internal production of oxalate by the liver, and excretion of oxalate by the kidney all contribute to hyperoxaluria [4]. High oxalate accumulation in the renal tubules induces CaOx crystal formation and renal cell injury, which promote the progression of CaOx urolithiasis.

Numerous studies have confirmed an association between CaOx crystal deposition in the kidneys and renal epithelial injury since Randall emphasized the importance of renal damage in stone formation [5, 6]. Many studies have indicated that oxidative stress and inflammation are important pathologies for kidney stone formation [7, 8]. Clinical studies have also reported that the kidneys of patients with CaOx stones were under oxidative stress [9]. Renal tubular epithelial cell overproduction of reactive oxygen species (ROS) is attributable to oxidative stress under conditions of high oxalate stimulation, which triggers epithelial cell injury, inflammation, and ultimately, cell apoptosis [10, 11]. ROS-induced cell injury is an initial mechanism of crystal nucleation, attachment, and retention [7, 12, 13].

Nuclear factor-κB (NFκB) is a nuclear transcription factor involved in inflammation and immune responses. NFκB usually exists in the cytoplasm in the form of dimers. Inhibitor of NFκB (IκB) binds to the NFκB dimer to inhibit NFκB phosphorylation and activation [14]. Following stimulation by cytokines or ROS, IκBα is phosphorylated and depolymerized with the NFκB dimer. The released NFκB dimers are activated by phosphorylation and can then be transported to the nucleus to regulate gene expression [15]. Osteopontin (OPN) plays an important role in the development of urolithiasis. Oxalate induces OPN expression by activating NFκB in tubular cells [16]. OPN also induces NFκB activation through the phosphorylation and degradation of IκBα by inducing IK kinase activity [14].

Solute carrier family 26 member 6 (Slc26a6) is an important protein that mediates oxalate transport, and it is expressed mainly in the apical membrane of the intestine and kidneys. In the intestine, Slc26a6 on the apical membrane of intestinal epithelial cells can transport Ox2− from the blood to the intestinal lumen (oxalate secretion) through Cl/Ox2− exchange [17]. In the kidneys, Slc26a6 is located in the proximal tubular epithelial cell side of the renal tubular cell and can transfer oxalate from the blood to the urine through the Cl/Ox2− exchange (oxalate secretion) [18].

Ox2− also can be transferred from the urine to blood via SO42−/Ox2− exchange (oxalate reabsorption). Many studies have shown that the level of Slc26a6 expression is highly correlated to oxalate homeostasis [19]. Based on these theories and studies, we hypothesized that the expression of Slc26a6 in NRK-52E cells could affect oxalate absorption and activate the NFκB/OPN pathway by regulating the degree of oxidative stress. In this study, we attempted to upregulate and downregulate Slc26a6 expression in NRK cells to explore whether it plays a key role in ROS production in NRK cells stimulated with high oxalate.

2. Materials and Methods

2.1. Cell Culture

The normal rat proximal tubular epithelial cell line (NRK-52E) was obtained from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). Cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) (HyClone, CT, USA) supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY, USA) at 37°C under a humidified 5% CO2 atmosphere.

2.2. Construction of Lentivirus with Slc26a6 or siRNA-Slc26a6

The Slc26a6 sequence (gene ID: 301010) was chosen according to the National Center for Biotechnology Information (NCBI) GenBank. To knock down Slc26a6 expression, lentiviral vector piLenti-siRNA-red fluorescent protein- (RFP-) based short hairpin RNA (shRNA) against Slc26a6 was constructed, and the targeting sequence of shSlc26a6 was 5-GGGAACTACTCAAGCTAAT-3 [17]. The sequences with red fluorescent protein (RFP) were synthesized and inserted into the vector pWSLV and pilentivirus as pWSLV-05-Slc26a6 and piLenti-siRNA (Slc26a6), respectively. The plasmid containing the coding sequence of Slc26a6 was purchased from Genecopoeia™, and 293T cells were seeded in 10 cm dishes until they reached 80–90% confluence. The transfection complex was directly added to each dish, and the cells were incubated in a CO2 incubator at 37°C overnight. A lentivirus particle-containing culture medium was harvested 48 h post-transfection. The final titers of the lentiviral vector were determined to contain 108 TU/mL.

2.3. Stable Transfection of NRK-52E Cells

pWSLV-05-Slc26a6, piLenti-siRNA (Slc26a6), and pLenti-vector were directly transfected into NRK-52E cells, and the medium was removed after 24 h. For stable transfection, the cells were cultured in DMEM medium containing 2.0 μg/mL puromycin (Beyotime Biotechnology, Shanghai, China) and the selective medium was changed after 48 h. The NRK cells in our experiment were divided into normal (NRK-52E), lv-Slc26a6 transgenic (NRK-Slc26a6), siRNA-Slc26a6 transgenic (NRK-siRNA), and vector transgenic (NRK-vector) NRK cells.

2.4. Western Blotting

Cells were lysed in NP-40 with 1.0 mM protease inhibitor phenylmethanesulfonyl fluoride (PMSF) (Beyotime Biotechnology, Shanghai, China) and 1.0 mM phosphoproteinase inhibitors (Servicebio, Hubei, China). The protein concentration was measured using the bicinchoninic acid (BCA) protein assay kit (Beyotime Biotechnology, Shanghai, China). After diluting the protein sample with 5x loading buffer and boiling for 10 min, it was loaded equally on a sodium dodecyl sulfate- (SDS-) 10% polyacrylamide gel and electrophoresed, and then the proteins were transferred onto polyvinylidene fluoride (PVDF) membranes. The PVDF membranes were blocked with 5% bovine serum albumin (BSA) for 2 h and probed with primary antibodies against Slc26a6 (1 : 200, sc-26728, Santa Cruz Biotechnology, CA, USA), NADPH oxidase 2 (Nox2, 1 : 200, 19013-1-AP, Proteintech, Hubei, China), Nox4 (1 : 200, 14347-1-AP, Proteintech, Hubei, China), NFκB p65 (1 : 500, GB11142, Servicebio, Hubei, China), NFκB-p65 (phosphorylated [p]-Ser536, 1 : 500, 11014, Signalway Antibody Co., Ltd, MD, USA), IκBα (1 : 500, GB13212-1, Servicebio, Hubei, China), IκBα (p-Ser32/36, 1 : 500, 11152, Signalway Antibody Co., Ltd, MD, USA), and OPN (1 : 200, 22952-1-AP, Proteintech, Hubei, China) at 4°C overnight. After three washes with Tris-buffered saline plus Tween (TBST), the PVDF membranes were incubated with HRP-conjugated anti-goat and anti-rabbit antibodies (1 : 5000, Boster Biological Technology Co., Ltd, China) for 2 h. Finally, the membranes were washed with TBST three times, and the blots were visualized with enhanced chemiluminescence (ECL) reagent using Bio-Rad Clarity Western ECL substrate (Bio-Rad Laboratories, CA, USA). Anti-β-actin was used to normalize the protein expression, and each Western blot was repeated in triplicate.

2.5. Immunofluorescence (IF)

Cells were cultured until they reached 80% confluence, and then they were fixed with 4% paraformaldehyde for 15 min, followed by permeabilization with 0.5% Triton X-100 for 20 min and blocking with BSA for 30 min. After washing with phosphate-buffered saline (PBS), the cells were incubated with an anti-Slc26a6 antibody (1 : 50) overnight at 4°C and then probed with anti-goat IgG FITC for 1 h at 25°C. The cells were washed in PBS plus Tween (PBST), treated with 4,6-diamidino-2-phenylindole (DAPI) for 5 min, and then the fluorescent signals of both assays were observed using a BX53 microscope (Olympus, Tokyo, Japan). The fluorescence intensities were determined using the ImageJ software.

2.6. Real-Time qPCR

Using the TRIzol method, total RNA was extracted from cells, and then cDNA was synthesized using the cDNA Master Mix for quantitative polymerase chain reaction (qPCR, Takara Bio Inc., Japan) following the manufacturer’s instructions. PCR was performed in a reaction volume of 20 μL containing SYBR Green using a CFX Connect Real-Time PCR System (Bio-Rad, CA, USA). The level of β-actin mRNA expression was measured as an endogenous reference and used for normalization. The results were calculated using the 2−∆∆Ct method to analyze differences in mRNA expression levels between samples. The primers for Slc26a6 used in this experiment were as follows: forward, CTTCGGTTTTGTGGTCACCT and reverse, TTTAACCAGCACCAACACCA.

2.7. Lactate Dehydrogenase (LDH) Assay

Total intracellular lactate dehydrogenase (LDH) was measured to detect the cell injury using an LDH measuring kit (C0017, Beyotime Biotechnology, Shanghai, China). Cells were seeded in 96-well plates at a concentration of 5 × 103 cells/well, and the medium was replaced with DMEM without FBS, followed by treatment with or without 700 μM oxalate [20] for 12 h. Then the supernatants were collected and measured according to the instructions to determine the LDH release activity, which was presented as the fold increase over the control group levels.

2.8. Cell Viability Detection Using CCK-8

Different cells were seeded at a concentration of 5 × 103 cells/well in 96-well plates and incubated overnight. The cells were treated with or without oxalate (700 μM) for 72 h [20]. During the treatment, the cell viability change was measured using a CCK-8 assay kit according to the instructions.

2.9. Lipid Peroxidation (Malondialdehyde, MDA) Measurement

Lipid peroxidation was measured as the malondialdehyde (MDA) content, which was determined using the kit according to the instructions (S0131, Beyotime Biotechnology, Shanghai, China). The MDA increment rates were expressed as percentages (%).

2.10. Superoxide Dismutase (SOD) Activity Measurement

Superoxide dismutase activity (SOD) was measured by kit (S0101, Beyotime Biotechnology, Shanghai, China), and the protocol was performed according to the manufacturer’s instructions. The change in SOD activity from with to without oxalate treatment was expressed as a percentage (%).

2.11. Annexin V/PI Staining and Flow Cytometric Analysis

The early and late apoptotic stages of four kinds of cells were identified and quantified using an Annexin V-FITC/PI detection kit (40303, Yeasen, Shanghai, China). After exposure to oxalate (700 μM) for 24 h, the early and late apoptotic cells were quantified [20]. The protocol was performed according to the manufacturer’s instructions. The apoptotic cells increment rate was expressed as %.

2.12. Preparation of Ultrathin Sections for TEM

After 700 μM oxalate treatment for 24 h, cells were fixed in 5% glutaraldehyde at 4°C [21]. The cells were post-fixed with 1% osmium tetroxide for 1 h and embedded in epoxy resin. Ultrathin sections were subsequently stained with aqueous uranyl acetate/lead citrate and observed using an FEI transmission electron microscope (TEM) at 200 kV at the Center for Instrumental Analysis and Metrology, Institute of Virology, Chinese Academy of Science.

2.13. Detection of Total Intracellular ROS

Intracellular ROS production was detected using an ROS assay kit (50101, Yeasen, Shanghai, China). Briefly, cells were seeded in six-well plates and treated with or without 700 μM of oxalate. After 3 h, the cells were treated with 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA, 10 μM) for 30 min. Then, the cells were collected and suspended in 200 μL PBS. Intracellular ROS levels were measured using flow cytometry (BD Biosciences, NY, USA), and all determinations were performed in triplicate. The ROS generation increment rate was expressed as a percentage (%).

2.14. Animal Experiments

Nine male Sprague-Dawley rats (275–300 g) were obtained from the Animal Center of Tongji Medical College, Huazhong University of Science and Technology. They were reacclimatized to a 12 h light/dark cycle at 23°C for 1 week prior to the start of the experiments in a specific pathogen-free animal house with a relative humidity of 45%–55%. They were allowed free access to a standard laboratory chow diet and were randomly divided into three groups of three rats each: normal control (NC), siRNA, and vector groups. The experimental protocol was conducted in accordance with the institutional ethical committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, according to the “Guidelines for Experimental Animal Ethical Committee of Huazhong University of Science and Technology.”

2.15. Lentivirus Transfection

The rats were placed in the prone position and anesthetized with sodium pentobarbital (40 mg/kg). Lentivirus subcapsular renal transfection was accomplished according to a previously published protocol [22], and every effort was made to minimize animal suffering. The NC, siRNA, and vector groups were injected with physiological saline, lentivirus-siRNA, and lentivirus-vector, respectively.

2.16. Detection of Crystal Formation

Ethylene glycol (EG) and ammonium chloride (NH4Cl) were dissolved in water to 1% and 0.5% concentrations, respectively. After a 2-week treatment, the rats were euthanized under anesthesia, the kidneys were removed, and von Kossa staining was used to identify crystal formation.

2.17. Detection of ROS

The rat kidney tissues were quickly frozen, cut to a thickness of 8 μm at an optimized cutting temperature, and mounted on glass slides [23]. Superoxide generation was measured by staining the tissue with dihydroethidium (DHE) for 30 min protected from light. Fluorescence images were captured using an Olympus BX53 fluorescence microscope (Olympus, Tokyo, Japan).

2.18. Terminal Deoxynucleotidyl Transferase dUTP Nick-End Labeling (TUNEL) Assay

The terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay was conducted using a TUNEL detection kit according to the manufacturer’s instructions (11684817910, Roche, Basel, Switzerland). Briefly, sections were incubated with 0.1% Triton X-100 and 0.1% sodium citrate for 8 min at room temperature and then washed with TBS. This was followed by incubation with a mixture of 3% BSA and 20% calf serum for 30 min at room temperature. After removing the serum, TUNEL reaction liquid was added to the sections, which were incubated for 60 min at 37°C, and then washed with TBS. The nuclei were counterstained with DAPI (Servicebio, Hubei, China). Images were captured using an Olympus BX53 fluorescence microscope (Olympus, Tokyo, Japan).

2.19. Statistical Analysis

The results were analyzed using GraphPad Prism 6.0 (GraphPad Software, San Diego, CA, USA) and are presented as deviation (SD). An unpaired -test was performed to analyze the differences between any two groups, and differences were considered significant at .

3. Results

3.1. Transgenic Cell Confirmation

According to the results of the quantitative polymerase chain reaction (qPCR), Western blotting, and immunofluorescence (IF), lentivirus-small interfering RNA (lv-siRNA) reduced Slc26a6 expression successfully in NRK cells while lv-Slc26a6 increased the expression (Figure 1).

3.2. Effects of Oxalate and Slc26a6 Expression on NRK-52E Cell Viability

After exposure to oxalate, the cells were analyzed using the cell counting kit-8 (CCK-8) assay, which indicated that the viability of NRK-Slc26a6 cells was decreased more than that of other groups, while a lower Slc26a6 expression ameliorated the reduction of cell viability (Figure 2(a)).

3.3. Higher Slc26a6 Expression Increased Oxalate-Mediated Cell Injury

To further analyze the effect of lower Slc26a6 levels on oxalate-induced cell injury, the LDH release activity was detected. Exposure of the cells to oxalate (700 μM) for 12 h caused the release of LDH in the group with higher Slc26a6 expression (Figure 2(b)). In contrast, the siRNA-Slc26a6 transgenic NRK cell (NRK-siRNA) group showed a higher decrease in the oxalate-induced LDH leakage than that of the control groups (normal NRK cells [NRK-52E] and vector transgenic NRK cells [NRK-vector]).

3.4. Higher Slc26a6 Expression Increased Oxalate-Mediated Cell Apoptosis

The fluorescein isothiocyanate (FITC)/propidium iodide (PI) apoptosis assay was performed to assess the mode of cell death caused by oxalate toxicity. FITC/PI staining and flow cytometry analysis revealed that 81.00 ± 1.90, 82.32 ± 0.80, 83.00 ± 0.92, and 82.85 ± 1.37% of the untreated NRK-52E, lv-Slc26a6 transgenic NRK (NRK-Slc26a6), NRK-siRNA, and NRK-vector cells, respectively, were viable. After exposure to oxalate for 24 h, viable cells were significantly decreased. The number of viable cell was reduced to 63.44 ± 2.18% (NRK-52E), 53.70 ± 2.02% (NRK-Slc26a6), 73.21 ± 1.75% (NRK-siRNA), and 66.83 ± 1.81% (NRK-vector; Figure 2(c)). The rate of increase in apoptotic cells was expressed as a graph in Figure 2(d).

3.5. Higher Slc26a6 Expression Increased Crystal Adhesion to Cells

After exposure to oxalate (700 μM) for 24 h, a light microscope was used to observe the crystal formation. The results showed that the higher Slc26a6 (NRK-Slc26a6) group accumulated the most calcium oxalate monohydrate (COM) cell adhesion, whereas NRK-siRNA had the least (Figure 3(a)).

3.6. Oxalate Induced More Intracellular Vesicles in the Higher Slc26a6 Group in Transmission Electron Microscopy (TEM) Analysis

After treatment with 700 μM oxalate for 24 h, fixed cells were observed using transmission electron microscopy (TEM), which showed that bigger intracellular vesicles were produced in the higher Slc26a6 group than in the control group. Compared to the control groups, smaller intracellular vesicles and more normal-shaped cells were observed in the lv-siRNA group (Figure 3(b)). No apparent changes were observed in the NRK-52E and NRK-vector groups.

3.7. Higher Slc26a6 Expression Induced Higher ROS Production

The DCFH-DA fluorescence was measured to determine the total intracellular ROS levels. NRK-Slc26a6 significantly increased the ROS generation compared with NRK-52EE and NRK-vector after oxalate exposure (Figure 4(a)).

3.8. Higher Slc26a6 Expression Enhanced Lipid Peroxidation Injury in Cells Exposed to Oxalate

MDA levels and SOD activity were examined as markers of lipid peroxidation injury and oxidative stress. The MDA assay indicated that NRK-Slc26a6 enhanced the lipid peroxidation injury in cells exposed to oxalate (Figure 4(b)). In the NRK-Slc26a6 group, the SOD activity was markedly decreased compared to that in the control groups (Figure 4(c)). Protein expression of NADPH oxidase (Nox) subunits changed in the different groups.

Before oxalate treatment, the Western blot showed that the four cell types expressed similar Nox2 and Nox4 levels. After exposure to 700 μM oxalate for 24 h, the four cell types were lysed to measure Nox2 and Nox4. Compared to the NRK-52EE cells and NRK-vector, NRK-siRNA expressed less Nox2 and NRK-Slc26a6 expressed more Nox4 protein than the controls did (Figure 4(d)).

3.9. Less Slc26a6 Expression Decreased p-p65 and p-IκBα Expression in Cells Exposed to Oxalate

The expressions of p65, p-p65, IκBα, and p-IκBα in cells were measured using a Western blot assay. The results indicated that the four cell types expressed similar p65, p-p65, IκBα, and p-IκBα protein levels before oxalate treatment, but the NRK-Slc26a6 group expressed more p-p65 and p-IκBα and NRK-siRNA expressed less p-p65 and p-IκBα than the control groups did (Figure 5(a)). The changes in protein expression levels between values before and after oxalate exposure are shown as plot graphs. p-p65 and p-IκBα increased significantly in the NRK-Slc26a6 group and decreased in NRK-siRNA (Figures 5(b)5(e)).

3.10. Less Slc26a6 Expression Decreased OPN Expression in Cells Exposed to Oxalate

A comparison of the OPN expression of cells before and after oxalate treatment showed that it was more significantly increased in N-26 cells than it was in control cells. However, NRK-siRNA ameliorated the increase compared to that of the control cells (Figures 5(f) and 5(g)).

3.11. lv-siRNA Subcapsular Transfection Reduced Expression of Slc26a6 in Kidney Tissue rather than Duodenum

After lv-siRNA renal subcapsular injection, the Slc26a6 expression levels of the kidney and duodenum were analyzed using IHC. The result indicated that the lv-siRNA group expressed less Slc26a6 in the kidney than the other groups did, while levels in duodenum were not altered significantly (Figures 6(a) and 6(b)).

3.12. Lower Slc26a6 Expression in Rat Kidneys Induced Less SOD Generation and Cell Apoptosis

ROS production was detected in the three groups using DHE fluorescence. As shown in Figure 6(c), lower Slc26a6 expression in the rat kidneys produced less SOD than higher expression did. Furthermore, to assess cell injury and apoptosis, a TUNEL assay was performed, and the result (Figure 6(d)) indicated that the lower Slc26a6 expression in rat kidneys induced less cell apoptosis.

3.13. Lower Slc26a6 Expression in Rat Kidneys Induced Less Crystal Formation

To assess whether crystal formation was reduced after lv-siRNA transfection, von Kossa staining was performed, and the results indicate that the lv-siRNA group significantly attenuated the crystal formation after treatment with 1.0% EG and 0.5% NH4Cl treatment (Figure 6(e)).

3.14. Lower Slc26a6 Expression in Rat Kidneys Induced Less p-p65, p-IκBα, and OPN Expression

The Western blot analysis indicates that p-p65, p-IκBα, and OPN were greatly decreased in the lv-siRNA-infected rats compared with levels in the control and lv-vector-infected rats, whereas p65 and IκBα showed no significant difference among the three groups (Figure 7).

4. Discussion

The urinary oxalate concentration is closely related to the condition of the kidney, which is responsible for 90% of the oxalate excretion [19]. As a key oxalate transporter, Slc26a6 is closely related to oxalate homeostasis in vivo [24]. Studies have shown that mice without Slc26a6 expression exhibited significantly elevated serum and urinary oxalate levels [25]. The expression of Slc26a6 is somewhat correlated to stone formation [18, 26]. Slc26a6 expression in the kidney may account for the oxalate homeostasis and stone formation. The expression of Slc26a6 in NRK cells was upregulated and downregulated using lentivirus transfection in our study, and then the cells were stimulated with oxalate followed by measurement of cell viability and ROS production.

Both oxalate and COM crystals have abrasive effects on the renal epithelial cells through free radicals [13]. Oxalate can be excreted in urine through renal epithelial cells, and oxalate in urine is also reabsorbed by renal epithelial cells [27]. The oxalate transporter, Slc26a6, mediates the transport of oxalate into and out of the renal epithelial cell. The level of Slc26a6 expression could affect the oxalate absorption of cells. In our previous study, oxalate at a concentration of 700 μM decreased NRK-52E cell viability and increased intracellular ROS production significantly [20]. In the present study, 700 μM oxalate was used to detect the different cell characteristics, and the results indicate that the highest Slc26a6 group (NRK-Slc26a6) accumulated more crystals than the control group did. CaOx crystals injure cells by damaging cell membranes and producing lipid mediators and excessive ROS, which lead to an imbalance between oxidants and antioxidants, with malfunctioning of the mitochondria [28, 29]. The TEM analysis showed that NRK-Slc26a6 cells produced bigger intracellular vesicles than other cells did, which indicates more injury was induced in the NRK-Slc26a6 cells [30]. A previous in vitro study reported that cell membrane vesicles are implicated in crystallization [31]. To further verify the effect on cell viability, a CCK8 assay was performed, and NRK-Slc26a6 cells showed lower cell viability than the control cells did and NRK-siRNA ameliorated the reduced cell viability induced by oxalate treatment, which was consistent with the cell apoptosis measurement. The results of this study indicate that NRK cells with higher Slc26a6 expression (NRK-Slc26a6) exhibited higher levels of injury from oxalate exposure, while lower Slc26a6 expression caused less injury than that of the control.

ROS, which have been shown to play a principal role in many physiological and pathophysiological processes, can be produced by Nox [32]. Nox4 and Nox2 are the two predominant isoforms in the kidneys [20, 33, 34]. In contrast to Nox2, Nox4 produces hydrogen peroxide rather than superoxide [35]. Oxalate exposure regulated mRNA expression of Nox subunits in a renal epithelial-derived cell line [36]. Zhang et al. [20] demonstrated that MitoTEMPO, a mitochondria-targeted antioxidant, increased the protein expression of Nox4 compared with the control group exposed to oxalate [20]. Consistent with this conclusion, we observed that the protein expression of Nox4 was increased in NRK-Slc26a6 and Nox2 was decreased in NRK-siRNA after exposure to oxalate. Furthermore, ROS and MDA levels were increased by oxalate treatment in NRK-Slc26a6.

OPN is a phosphoprotein considered to be a key macromolecular modulator in the development of urolithiasis [37]. OPN expression is upregulated in the cortical tubules of the kidney after renal epithelium cell injury after stimulation with high concentrations of oxalate or COM adhesion [16, 3840]. OPN plays a crucial role in the adhesion process of CaOx crystals to the renal tubular cells in stone formation [41]. Tozawa et al. reported that OPN could be upregulated by activation of the NFκB signaling pathway [16].

NFκB is a set of nuclear transcription factor proteins that usually exist in the cytoplasm in the form of dimers [15]. The most common forms of NFκB are p65-p65 and p65-p50. IκB binds to the NFκB dimer to inhibit NFκB phosphorylation activation. ROS lead to IκBα phosphorylation and depolymerization with the NFκB dimer, and the released NFκB dimers are activated by phosphorylation [15]. The NFκB signaling pathway also mediates OPN pathway activation, which is responsible for crystal adhesion [42]. Consistently, in our study, OPN, p-p65, and p-IκB expression was induced in NRK-Slc26a6 after oxalate exposure, which indicates that the NRK-Slc26a6 group may have absorbed more oxalate or COM into cells than other groups did, and the NRK-siRNA cells expressed lower OPN protein and p-p65 and p-IκB levels after oxalate treatment.

The present study results indicate that high expression of Slc26a6 in NRK cells could absorb more oxalate into cells and increase COM crystal adhesion (Figure 8(a)). The interaction between COM and the cell membrane leads to cell injury, resulting in more ROS production and NFκB/OPN pathway activation in NRK cells, leading to more COM adhesion (Figure 8(b)) [28, 43]. The cellular studies indicate that low Slc26a6 expression levels in the kidney may protect it from urolithiasis formation.

Furthermore, we transfected lv-siRNA into rats’ kidneys to identify SOD generation. The TUNEL assay showed NFκB and OPN expression level changes and crystal formation. Because Slc26a6 is mainly expressed in both the duodenum and kidney, subcapsular injection was used to study the kidney separately [22]. After infection for 2 weeks, an IHC assay was performed, and the results indicate that the expression of Slc26a6 decreased significantly in the kidney but was not altered in the duodenum. Furthermore, the other results were consistent with the in vitro study.

There are some limitations to our study, which are worth mentioning. Firstly, in the present study, we just did an in vitro and vivo study, so further clinical verification is necessary. Secondly, more studies focusing on the association between oxalate transportation and other molecular proteins, which we did not investigate in this study, are needed [44]. Thirdly, we only downregulated the expression of Slc26a6, so further study knocking out the gene is needed. Fourthly, larger numbers of animal experiments are needed in future to verify the Slc26a6 function.

5. Conclusion

In conclusion, we propose that downregulation of Slc26a6 expression attenuated ROS production to reduce crystal formation.

Data Availability

The data of the materials and methods and conclusions to support the findings of this study are included within the article. If any other data may be needed, please contact the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflict of interest.


The work was funded by the National Natural Science Foundation of China (grant no. 81400706) and Graduates’ Innovation Fund, Huazhong University of Science and Technology (grant no. 5003540053).


  1. F. L. Coe, A. Evan, and E. Worcester, “Kidney stone disease,” The Journal of Clinical Investigation, vol. 115, no. 10, pp. 2598–2608, 2005. View at: Publisher Site | Google Scholar
  2. R. T. Alexander, B. R. Hemmelgarn, N. Wiebe et al., “Kidney stones and kidney function loss: a cohort study,” BMJ, vol. 345, article e5287, 2012. View at: Publisher Site | Google Scholar
  3. S. R. Khan, “Animal models of kidney stone formation: an analysis,” World Journal of Urology, vol. 15, no. 4, pp. 236–243, 1997. View at: Publisher Site | Google Scholar
  4. A. Khan, “Prevalence, pathophysiological mechanisms and factors affecting urolithiasis,” International Urology and Nephrology, vol. 50, no. 5, pp. 799–806, 2018. View at: Publisher Site | Google Scholar
  5. S. R. Khan, P. N. Shevock, and R. L. Hackett, “Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis,” The Journal of Urology, vol. 147, no. 1, pp. 226–230, 1992. View at: Publisher Site | Google Scholar
  6. R. de Water, E. R. Boevé, P. P. van Miert et al., “Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals,” Scanning Microscopy, vol. 10, no. 2, pp. 591–601, 1996. View at: Google Scholar
  7. A. Abhishek, S. Benita, M. Kumari et al., “Molecular analysis of oxalate-induced endoplasmic reticulum stress mediated apoptosis in the pathogenesis of kidney stone disease,” Journal of Physiology and Biochemistry, vol. 73, no. 4, pp. 561–573, 2017. View at: Publisher Site | Google Scholar
  8. A. Albert, V. Tiwari, E. Paul et al., “Expression of heterologous oxalate decarboxylase in HEK293 cells confers protection against oxalate induced oxidative stress as a therapeutic approach for calcium oxalate stone disease,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 32, no. 1, pp. 426–433, 2017. View at: Publisher Site | Google Scholar
  9. C. Boonla, R. Wunsuwan, K. Tungsanga, and P. Tosukhowong, “Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis,” Urological Research, vol. 35, no. 4, pp. 185–191, 2007. View at: Publisher Site | Google Scholar
  10. S. Chaiyarit and V. Thongboonkerd, “Changes in mitochondrial proteome of renal tubular cells induced by calcium oxalate monohydrate crystal adhesion and internalization are related to mitochondrial dysfunction,” Journal of Proteome Research, vol. 11, no. 6, pp. 3269–3280, 2012. View at: Publisher Site | Google Scholar
  11. B. Poljsak, D. Šuput, and I. Milisav, “Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 956792, 11 pages, 2013. View at: Publisher Site | Google Scholar
  12. J. A. Jonassen, L. C. Cao, T. Honeyman, and C. R. Scheid, “Mechanisms mediating oxalate-induced alterations in renal cell functions,” Critical Reviews in Eukaryotic Gene Expression, vol. 13, no. 1, pp. 55–72, 2003. View at: Publisher Site | Google Scholar
  13. J. Zuo, A. Khan, P. A. Glenton, and S. R. Khan, “Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague–Dawley rats,” Nephrology Dialysis Transplantation, vol. 26, no. 6, pp. 1785–1796, 2011. View at: Publisher Site | Google Scholar
  14. R. Das, S. Philip, G. Mahabeleshwar, A. Bulbule, and G. Kundu, “Osteopontin: it’s role in regulation of cell motility and nuclear factor κB-mediated urokinase type plasminogen activator expression,” IUBMB Life (International Union of Biochemistry and Molecular Biology: Life), vol. 57, no. 6, pp. 441–447, 2005. View at: Publisher Site | Google Scholar
  15. B. Hoesel and J. A. Schmid, “The complexity of NF-κB signaling in inflammation and cancer,” Molecular Cancer, vol. 12, no. 1, p. 86, 2013. View at: Publisher Site | Google Scholar
  16. K. Tozawa, T. Yasui, A. Okada et al., “NF–κB activation in renal tubular epithelial cells by oxalate stimulation,” International Journal of Urology, vol. 15, no. 10, pp. 924–928, 2008. View at: Publisher Site | Google Scholar
  17. H. Jiang, G. Pokhrel, Y. Chen et al., “High expression of SLC26A6 in the kidney may contribute to renal calcification via an SLC26A6-dependent mechanism,” PeerJ, vol. 6, article e5192, 2018. View at: Publisher Site | Google Scholar
  18. E. Ohana, N. Shcheynikov, O. W. Moe, and S. Muallem, “SLC26A6 and NaDC-1 transporters interact to regulate oxalate and citrate homeostasis,” Journal of the American Society of Nephrology, vol. 24, no. 10, pp. 1617–1626, 2013. View at: Publisher Site | Google Scholar
  19. H. Brzica, D. Breljak, B. C. Burckhardt, G. Burckhardt, and I. Sabolić, “Oxalate: from the environment to kidney stones,” Archives of Industrial Hygiene and Toxicology, vol. 64, no. 4, pp. 609–630, 2013. View at: Publisher Site | Google Scholar
  20. J. Zhang, Q. Wang, C. Xu et al., “MitoTEMPO prevents oxalate induced injury in NRK-52E cells via inhibiting mitochondrial dysfunction and modulating oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 7528090, 9 pages, 2017. View at: Publisher Site | Google Scholar
  21. M. A. Abbas, D. Badran, and A. Disi, “Effect of nordihydroguaiaretic acid on spermatogenesis and fertility in rats,” Andrologia, vol. 50, no. 3, article e12916, 2018. View at: Publisher Site | Google Scholar
  22. E. J. Zmuda, C. A. Powell, and T. Hai, “A method for murine islet isolation and subcapsular kidney transplantation,” Journal of Visualized Experiments, no. 50, article e2096, 2011. View at: Publisher Site | Google Scholar
  23. R. Li, X. Meng, Y. Zhang et al., “Testosterone improves erectile function through inhibition of reactive oxygen species generation in castrated rats,” PeerJ, vol. 4, article e2000, 2016. View at: Publisher Site | Google Scholar
  24. P. S. Aronson, “Role of SLC26A6-mediated Cl-oxalate exchange in renal physiology and pathophysiology,” Journal of Nephrology, vol. 23, pp. S158–S164, 2010. View at: Google Scholar
  25. Z. Jiang, J. R. Asplin, A. P. Evan et al., “Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6,” Nature Genetics, vol. 38, no. 4, pp. 474–478, 2006. View at: Publisher Site | Google Scholar
  26. J. M. Whittamore and M. Hatch, “The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man,” Urolithiasis, vol. 45, no. 1, pp. 89–108, 2017. View at: Publisher Site | Google Scholar
  27. H. Koul, S. Ebisuno, L. Renzulli, M. Yanagawa, M. Menon, and C. Scheid, “Polarized distribution of oxalate transport systems in LLC-PK1 cells, a line of renal epithelial cells,” American Journal of Physiology-Renal Physiology, vol. 266, no. 2, pp. F266–F274, 1994. View at: Publisher Site | Google Scholar
  28. S. Joshi, A. B. Peck, and S. R. Khan, “NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 462361, 18 pages, 2013. View at: Publisher Site | Google Scholar
  29. L. C. Cao, T. Honeyman, J. Jonassen, and C. Scheid, “Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells,” Kidney International, vol. 57, no. 6, pp. 2403–2411, 2000. View at: Publisher Site | Google Scholar
  30. H. K. Truchan, C. L. Cockburn, K. S. Hebert, F. Magunda, S. M. Noh, and J. A. Carlyon, “The pathogen-occupied vacuoles of Anaplasma phagocytophilum and Anaplasma marginale interact with the endoplasmic reticulum,” Frontiers in Cellular and Infection Microbiology, vol. 6, p. 22, 2016. View at: Publisher Site | Google Scholar
  31. J. M. Fasano and S. R. Khan, “Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study,” Kidney International, vol. 59, no. 1, pp. 169–178, 2001. View at: Publisher Site | Google Scholar
  32. B. Qin, Q. Wang, Y. Lu et al., “Losartan ameliorates calcium oxalate-induced elevation of stone-related proteins in renal tubular cells by inhibiting NADPH oxidase and oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2018, Article ID 1271864, 12 pages, 2018. View at: Publisher Site | Google Scholar
  33. K. Schröder, K. Wandzioch, I. Helmcke, and R. P. Brandes, “Nox4 acts as a switch between differentiation and proliferation in preadipocytes,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 2, pp. 239–245, 2009. View at: Publisher Site | Google Scholar
  34. S. Pendyala, I. A. Gorshkova, P. V. Usatyuk et al., “Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells,” Antioxidants & Redox Signaling, vol. 11, no. 4, pp. 747–764, 2009. View at: Publisher Site | Google Scholar
  35. I. Takac, K. Schröder, L. Zhang et al., “The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4,” Journal of Biological Chemistry, vol. 286, no. 15, pp. 13304–13313, 2011. View at: Publisher Site | Google Scholar
  36. S. R. Khan, A. Khan, and K. J. Byer, “Temporal changes in the expression of mRNA of NADPH oxidase subunits in renal epithelial cells exposed to oxalate or calcium oxalate crystals,” Nephrology Dialysis Transplantation, vol. 26, no. 6, pp. 1778–1785, 2011. View at: Publisher Site | Google Scholar
  37. X. Xiao, Z. Dong, X. Ye et al., “Association between OPN genetic variations and nephrolithiasis risk,” Biomedical Reports, vol. 5, no. 3, pp. 321–326, 2016. View at: Publisher Site | Google Scholar
  38. T. Umekawa, H. Tsuji, H. Uemura, and S. R. Khan, “Superoxide from NADPH oxidase as second messenger for the expression of osteopontin and monocyte chemoattractant protein-1 in renal epithelial cells exposed to calcium oxalate crystals,” BJU International, vol. 104, no. 1, pp. 115–120, 2009. View at: Publisher Site | Google Scholar
  39. Q. Xi, J. Ouyang, J. Pu, J. Hou, and S. Wang, “High concentration of calcium stimulates calcium oxalate crystal attachment to rat tubular epithelial NRK cells through osteopontin,” Urology, vol. 86, no. 4, pp. 844.e1–844.e5, 2015. View at: Publisher Site | Google Scholar
  40. S. R. Khan, S. Joshi, W. Wang, and A. B. Peck, “Regulation of macromolecular modulators of urinary stone formation by reactive oxygen species: transcriptional study in an animal model of hyperoxaluria,” American Journal of Physiology-Renal Physiology, vol. 306, no. 11, pp. F1285–F1295, 2014. View at: Publisher Site | Google Scholar
  41. T. Yasui, K. Fujita, K. Asai, and K. Kohri, “Osteopontin regulates adhesion of calcium oxalate crystals to renal epithelial cells,” International Journal of Urology, vol. 9, no. 2, pp. 100–108, 2002. View at: Publisher Site | Google Scholar
  42. J. Liu, Q. Liu, Y. Wan et al., “Osteopontin promotes the progression of gastric cancer through the NF-κB pathway regulated by the MAPK and PI3K,” International Journal of Oncology, vol. 45, no. 1, pp. 282–290, 2014. View at: Publisher Site | Google Scholar
  43. S. R. Khan, “Role of renal epithelial cells in the initiation of calcium oxalate stones,” Nephron Experimental Nephrology, vol. 98, no. 2, pp. e55–e60, 2004. View at: Publisher Site | Google Scholar
  44. R. Amin, J. Asplin, D. Jung et al., “Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria,” Kidney International, vol. 93, no. 5, pp. 1098–1107, 2018. View at: Publisher Site | Google Scholar

Copyright © 2018 Hongyang Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles